What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Cancer
His primary areas of investigation include Surgery, Pulmonary embolism, Internal medicine, Randomized controlled trial and Thrombosis.
Philip S. Wells interconnects Warfarin and Hazard ratio in the investigation of issues within Surgery.
His Pulmonary embolism research integrates issues from Antithrombotic, Predictive value of tests, Radiology, Vascular disease and Venous thrombosis.
His Internal medicine study frequently links to other fields, such as Cardiology.
His Randomized controlled trial research is multidisciplinary, relying on both Venous thromboembolism, Clinical trial and Confidence interval.
In his research on the topic of Thrombosis, Lost to follow-up, Popliteal vein and Groin is strongly related with Vein.
His most cited work include:
- Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (5057 citations)
- Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report (2635 citations)
- Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer (1148 citations)
What are the main themes of his work throughout his whole career to date?
Philip S. Wells spends much of his time researching Pulmonary embolism, Internal medicine, Surgery, Thrombosis and Venous thrombosis.
His Pulmonary embolism research incorporates themes from Venous thromboembolism, Radiology, Pre- and post-test probability, Intensive care medicine and D-dimer.
Internal medicine is closely attributed to Cardiology in his study.
Philip S. Wells has researched Surgery in several fields, including Odds ratio and Warfarin.
His Thrombosis study integrates concerns from other disciplines, such as Inferior vena cava, Vascular disease, Vein and Risk factor.
His work carried out in the field of Randomized controlled trial brings together such families of science as Thrombophilia, Anesthesia and Clinical trial.
He most often published in these fields:
- Pulmonary embolism (48.31%)
- Internal medicine (46.15%)
- Surgery (42.15%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (46.15%)
- Pulmonary embolism (48.31%)
- Thrombosis (37.54%)
In recent papers he was focusing on the following fields of study:
Philip S. Wells mostly deals with Internal medicine, Pulmonary embolism, Thrombosis, Venous thromboembolism and Intensive care medicine.
Much of his study explores Internal medicine relationship to Surgery.
His Pulmonary embolism study combines topics in areas such as Prospective cohort study, Venous thrombosis, Deep vein and Warfarin.
His Thrombosis research is multidisciplinary, relying on both Anesthesia, Randomized controlled trial, Stroke, Atrial fibrillation and Hazard ratio.
His Venous thromboembolism research includes elements of Anticoagulant therapy and Major bleeding.
He combines subjects such as Oral anticoagulant, Long term risk and Pre- and post-test probability with his study of Intensive care medicine.
Between 2015 and 2021, his most popular works were:
- Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism (327 citations)
- Apixaban to Prevent Venous Thromboembolism in Patients with Cancer (269 citations)
- Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report. (191 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Cancer
Philip S. Wells mainly focuses on Internal medicine, Pulmonary embolism, Thrombosis, Intensive care medicine and Randomized controlled trial.
His Internal medicine study frequently draws connections to adjacent fields such as Surgery.
Philip S. Wells interconnects Clinical trial and Edoxaban in the investigation of issues within Surgery.
His Pulmonary embolism research is multidisciplinary, incorporating elements of First episode, Lower risk, Prospective cohort study and Deep vein.
His work deals with themes such as Anesthesia and Confidence interval, which intersect with Thrombosis.
His research in Intensive care medicine intersects with topics in Venous thromboembolism, Venous thrombosis and Anticoagulant therapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
